# Chronic GVHD: Intersecting Aspects in Systemic and Ocular Disease

> **NIH NIH R13** · UNIVERSITY OF ILLINOIS AT CHICAGO · 2020 · $1

## Abstract

Abstract:
 Chronic ocular GVHD (oGVHD) has been recognized as an important complication after allogeneic
hematopoietic stem cell transplantation (HSCT) and is the leading cause of long-term morbidity and mortality
following allogeneic HSCT. The proposed meeting entitled “Chronic GVHD: Intersecting aspects in systemic
and ocular disease” will address a difficulty that is intrinsic in the area of dry eye and ocular surface disease
due to chronic ocular GVHD - the difficulty in disseminating information and developing new management
strategies in a fast-changing discipline (science and clinical treatment of ocular GVHD) where the stakeholders
come from multiple disparate pools (clinician, clinical trainees and researchers in ophthalmology, hematology,
oncology and immunology). This meeting is devoted to the intersection between ophthalmologist and
hematologists/oncologists working in the areas of chronic GVHD and dry eye/ocular surface disease. By
bringing together clinicians and scientists from different disciplines, including nationally recognized experts, this
meeting will lower the communication barrier and promote interdisciplinary research and education and
facilitate improvements in the management of patients with chronic ocular GVHD.
 We conducted the second Chronic GVHD Meeting on October 22, 2016 at the University of Illinois at
Chicago (UIC) College of Medicine (COM) learning center. We propose to model future meetings (2017-2022)
on the successful format of the 2016 meeting. The overall objective of this grant application is to request
support for aspects of the annual meeting for the next 5-year period for achieving three aims. To stimulate
clinical and translational interdisciplinary collaborations and new lines of research, the meeting will bring
together nationally recognized experts (hematologist/oncologists and ophthalmologists) for disseminating new
findings in the area of chronic systemic and ocular GVHD (Aim 1). To stimulate inter-institutional and
interdisciplinary opportunities in research, clinical practice and education, the meeting will bring together five
bone marrow transplant programs and six ophthalmology departments in the Chicago area to discuss
differences in their approach to HSCT and chronic GVHD management and impediments/opportunities in
clinical and research collaborations (Aim 2). To increase collaboration amongst junior and senior scientists in
the fields of hematology/oncology and ophthalmology, 20 travel awards will be made to increase the
participation of clinicians who are pursuing research career development and early stage basic science
researchers in the areas of ocular surface disease and GVHD (Aim 3). Preference will be given to women,
racial/ethnic minorities and persons with disabilities. The Chronic GVHD meeting has been planned in
accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical
Education (ACCME) under the sponsorship of University of Illinois at...

## Key facts

- **NIH application ID:** 10000148
- **Project number:** 5R13EY027189-05
- **Recipient organization:** UNIVERSITY OF ILLINOIS AT CHICAGO
- **Principal Investigator:** Sandeep Jain
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1
- **Award type:** 5
- **Project period:** 2016-08-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10000148

## Citation

> US National Institutes of Health, RePORTER application 10000148, Chronic GVHD: Intersecting Aspects in Systemic and Ocular Disease (5R13EY027189-05). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10000148. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*